Does high blood pressure cause hair loss? It is a question many people with hypertension ask, particularly when they notice increased shedding or thinning. The relationship is nuanced: there is currently no definitive clinical evidence that raised blood pressure directly causes hair loss. However, certain conditions that accompany hypertension — and some medications used to treat it — may contribute to hair thinning in some individuals. This article explores the potential indirect links, examines which antihypertensive medicines are associated with alopecia, outlines other causes to consider, and explains when to seek advice from your GP.

The Link Between High Blood Pressure and Hair Loss

There is no definitive clinical evidence that hypertension directly causes hair loss, but associated conditions and antihypertensive medications may contribute to hair thinning in some people.

Not sure if this is normal? Chat with one of our pharmacists →

Many people living with high blood pressure (hypertension) notice changes in their hair and wonder whether the two are connected. It is a reasonable question, and the relationship is more nuanced than a simple yes or no. Currently, there is no definitive clinical evidence that hypertension directly causes hair loss as a standalone mechanism. However, some of the conditions that may accompany high blood pressure — and certain medications used to treat it — may play a role in hair thinning or shedding in some individuals.

Hypertension is a common chronic condition: according to NHS and British Heart Foundation data, approximately 1 in 3 adults in the UK is affected. It is associated with broader cardiovascular and metabolic changes that can affect multiple body systems, including the skin and hair follicles. Stress and certain comorbidities — all of which may coexist with poorly controlled blood pressure — are well-recognised contributors to hair loss, though they are not direct consequences of raised blood pressure itself.

It is important to approach this topic with balance. Hair loss is common and multifactorial, and attributing it solely to blood pressure without a thorough clinical assessment would be an oversimplification. Understanding the potential indirect links can, however, help patients and clinicians make more informed decisions about investigation and management.

Useful resources: NHS: High blood pressure (hypertension); NHS: Hair loss (alopecia); British Heart Foundation: Blood pressure statistics.

How Hypertension May Affect Hair Growth

Hypertension may indirectly affect hair growth through stress-related telogen effluvium and coexisting conditions such as thyroid dysfunction or metabolic syndrome, rather than through a direct mechanism.

Hair follicles are sensitive to changes in blood supply, hormonal environment, and physiological stress. It has been hypothesised — though not conclusively established — that poorly controlled hypertension may impair microvascular circulation, potentially reducing oxygen and nutrient delivery to the scalp. Whether this is sufficient to affect the hair growth cycle in practice remains uncertain, and this mechanism should be regarded as speculative rather than proven.

Chronic psychological and physiological stress is both a recognised contributor to raised blood pressure and a well-established trigger for telogen effluvium — a form of diffuse hair loss in which a large number of hairs prematurely enter the resting (telogen) phase and subsequently shed. This creates a plausible indirect pathway between the stressors associated with hypertension and hair loss, even if raised blood pressure itself is not the direct cause.

Hypertension may also coexist with conditions that independently cause hair loss, including:

• Type 2 diabetes, which can affect peripheral circulation

• Thyroid dysfunction, which is a recognised independent cause of hair thinning

• Metabolic syndrome, which has been associated with androgenetic alopecia (pattern hair loss) in observational studies

These comorbidities may compound hair loss risk in people with high blood pressure, but they should be understood as conditions that may coexist and independently affect hair, rather than as direct consequences of hypertension. Inflammation, which underpins many cardiovascular conditions, has also been implicated in disrupting the hair follicle cycle, though the evidence base remains evolving. Clinicians should consider the broader systemic picture when assessing hair loss in a patient with hypertension.

Useful resources: NICE CKS: Telogen effluvium; PCDS: Hair loss assessment in primary care.

Can Blood Pressure Medications Cause Hair Loss?

Several antihypertensive drug classes — particularly beta-blockers — have been associated with drug-induced alopecia, typically diffuse and reversible, beginning 2–4 months after starting or changing treatment.

One of the most clinically relevant considerations is whether antihypertensive medications contribute to hair loss. Several classes of blood pressure medicines have been associated with drug-induced alopecia, though this is generally an uncommon or rare side effect, and the strength of evidence varies between drug classes. The mechanism is not fully understood; drug-induced hair loss is typically idiosyncratic and thought to involve telogen effluvium rather than a specific pharmacological pathway.

Experiencing these side effects? Our pharmacists can help you navigate them →

Beta-blockers (such as bisoprolol, atenolol, and propranolol) are among the antihypertensives most frequently cited in association with hair loss. Alopecia is listed as a reported adverse reaction in the Summary of Product Characteristics (SmPC) for some of these medicines. The precise mechanism is not established; earlier suggestions regarding androgen metabolism or scalp blood flow effects remain speculative.

ACE inhibitors (such as ramipril and lisinopril) and angiotensin II receptor blockers (ARBs) (such as losartan and candesartan) have occasionally been reported to cause hair thinning, and alopecia appears as a rare adverse reaction in some SmPCs. Robust clinical data remain limited.

Thiazide-like diuretics (such as indapamide and chlortalidone), which are commonly used in UK hypertension management, have also been associated with alopecia in some product information, though this is uncommon. There is no well-established evidence that these medicines cause clinically significant zinc or biotin deficiency.

Calcium channel blockers (such as amlodipine) are generally less frequently associated with hair loss, though individual reports exist.

Key points for patients:

• Hair loss from medication typically begins 2–4 months after starting or changing a drug

• It is usually diffuse rather than patchy

• It is often reversible upon discontinuation or switching to an alternative, under medical supervision

Patients should never stop blood pressure medication without consulting their GP or pharmacist, as uncontrolled hypertension carries serious risks including stroke and heart attack. If you suspect a medicine is causing hair loss, report it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), which allows patients and clinicians to report suspected adverse drug reactions and contributes to ongoing pharmacovigilance.

Useful resources: MHRA/EMC SmPCs for individual antihypertensive medicines; NICE NG136: Hypertension in adults — diagnosis and management; MHRA Yellow Card scheme.

Other Medical Causes of Hair Loss to Consider

Hair loss is multifactorial; common causes include androgenetic alopecia, thyroid disorders, iron deficiency, and telogen effluvium, all of which should be excluded before attributing hair loss to hypertension.

When assessing hair loss in someone with high blood pressure, it is essential not to attribute the symptom to hypertension or its treatment without ruling out other common and treatable causes. Hair loss is one of the most prevalent dermatological complaints in the UK, and its aetiology is frequently multifactorial.

Common medical causes of hair loss include:

• Androgenetic alopecia (male or female pattern hair loss) — the most common cause overall, driven by genetic and hormonal factors

• Thyroid disorders — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning; thyroid function testing (TSH) is appropriate in diffuse hair loss where clinically indicated

• Iron deficiency — particularly prevalent in women of reproductive age; serum ferritin is a key investigation

• Alopecia areata — an autoimmune condition causing patchy hair loss

• Telogen effluvium — triggered by physical or emotional stress, illness, surgery, significant weight loss, or nutritional deficiency

• Nutritional deficiencies — testing for specific micronutrients (such as vitamin D or zinc) should be guided by clinical suspicion or symptoms, rather than performed routinely

Hormonal changes associated with the menopause, polycystic ovary syndrome (PCOS), and the postpartum period are also significant contributors in women. Scalp conditions such as seborrhoeic dermatitis or tinea capitis (fungal infection of the scalp) should also be considered.

Red flags requiring prompt or urgent assessment include:

• Signs of scarring alopecia (scalp redness, scarring, follicular loss, or pustules)

• A boggy, tender scalp plaque (kerion), which may indicate tinea capitis — particularly important in children

• Systemic features suggesting infection or significant underlying illness

A thorough history — including medication review, dietary habits, recent illnesses, and family history — alongside targeted blood tests (typically a full blood count, ferritin, and TSH in diffuse hair loss, guided by clinical context) will usually identify the underlying cause. Hormone testing should be considered in women where there are clinical features of hyperandrogenism (such as in PCOS), rather than routinely. This approach is consistent with PCDS and NICE CKS guidance on the assessment of hair loss in primary care.

Useful resources: PCDS: Hair loss in primary care; NICE CKS: Female pattern hair loss; NICE CKS: Alopecia areata; NICE CKS: Tinea capitis; BAD Patient Information Leaflets.

When to Speak to Your GP About Hair Loss

See your GP if hair loss is sudden, patchy, accompanied by scalp changes, or begins shortly after starting a blood pressure medication; a blood count, ferritin, and TSH are the standard initial investigations.

Hair loss can be distressing, and knowing when to seek medical advice is important. Not all hair shedding requires urgent attention — it is normal to lose between 50 and 100 hairs per day — but certain patterns and associated symptoms warrant a GP consultation.

You should speak to your GP if you notice:

• Sudden or rapid hair loss over a short period

• Patchy or irregular hair loss rather than generalised thinning

• Hair loss accompanied by scalp redness, scaling, itching, pain, or scarring

• A boggy or tender area on the scalp, or pustules (which may suggest infection requiring prompt treatment)

• Associated symptoms such as fatigue, weight changes, or feeling unusually cold or warm (which may suggest thyroid disease)

• Hair loss that begins shortly after starting or changing a blood pressure medication

• Significant psychological distress related to hair changes

Your GP will typically take a detailed history and may arrange blood tests. In diffuse hair loss, this commonly includes a full blood count, serum ferritin, and thyroid function (TSH), guided by your symptoms and clinical findings. In women with features of hyperandrogenism, androgen levels may also be checked. Routine testing of all hormone or micronutrient levels is not generally recommended without clinical indication.

If the diagnosis is unclear, or if there are features suggesting scarring alopecia, suspected tinea capitis (particularly in children), or a need for specialist treatment, your GP can refer you to an NHS dermatologist. Please note that the title 'trichologist' is not a regulated healthcare profession in the UK; for NHS-funded specialist assessment, dermatology is the appropriate referral pathway.

For those already managing hypertension, it is particularly important to raise hair loss concerns with the clinician overseeing your blood pressure care. A medication review can be conducted safely, and alternative antihypertensives may be considered if a drug-related cause is suspected. Do not adjust or stop any prescribed medication independently.

Useful resources: NHS: Hair loss (alopecia); PCDS: Hair loss referral guidance; NICE CKS: Alopecia areata; NICE CKS: Tinea capitis.

Managing Hair Loss Alongside High Blood Pressure

Managing both conditions requires a coordinated approach: a GP may switch antihypertensives if a drug cause is suspected, while lifestyle measures, dietary balance, and topical minoxidil (with medical guidance) can support hair regrowth.

Managing hair loss when you also have high blood pressure requires a careful, coordinated approach that addresses both conditions without compromising cardiovascular safety. In many cases, once an underlying cause is identified and treated, hair regrowth is possible.

If a blood pressure medication is suspected as the cause, your GP may consider switching to an alternative antihypertensive from a different drug class, guided by NICE NG136 and your individual circumstances. There are several effective options available — including calcium channel blockers, ACE inhibitors, and ARBs — and finding a suitable alternative that controls blood pressure without affecting hair is often achievable. Any switch should be discussed with your prescriber, with the risks and benefits clearly documented.

General measures that support both cardiovascular and hair health include:

• A balanced diet rich in iron, zinc, and protein — consistent with NHS Eatwell Guide recommendations

• Stress management through techniques such as mindfulness, regular physical activity, and adequate sleep, all of which also benefit blood pressure

• Avoiding crash diets or extreme caloric restriction, which can trigger telogen effluvium and may worsen blood pressure control

• Regular blood pressure monitoring at home or via GP review, in line with NICE guideline NG136

For androgenetic alopecia specifically, topical minoxidil is available over the counter and has a reasonable evidence base for both men and women. However, patients should discuss this with their GP before use. Important UK SmPC cautions include:

• Seek medical advice before use if you have cardiovascular disease, as rare systemic absorption may occur

• Do not use on broken, inflamed, or infected scalp

• Not recommended during pregnancy or breastfeeding

• Systemic effects (such as fluid retention or unwanted facial hair) are uncommon but possible

• Age restrictions apply; check product labelling

The interaction between topical minoxidil's vasodilatory properties and existing antihypertensive therapy should be considered and discussed with your prescriber.

Oral minoxidil is increasingly used by specialists for hair loss but is not licensed for this indication in the UK. It should only be considered under specialist supervision, with appropriate cardiovascular monitoring, and is not suitable for self-initiation.

Ultimately, a joined-up approach — addressing lifestyle, reviewing medications, and treating any underlying deficiencies — offers the best chance of improving both hair health and blood pressure control over the long term.

Useful resources: NICE NG136: Hypertension in adults — diagnosis and management; MHRA/EMC SmPC: Regaine (minoxidil) cutaneous foam/solution; NHS Eatwell Guide; MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Frequently Asked Questions